← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2024Last known activity
Nov 1, 2024
Timeline
2010s
- Jan 1, 2015
HepaRegeniX GmbH— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (2)
- NCT06638502OfficialPhase 1/Phase 2Nov 1, 2024
- NCT06638502Lead sponsorPhase 1/Phase 2Nov 1, 2024
Details
- Founded
- Tübingen, DE Jan 1, 2015
- Last known activity
- Nov 1, 2024